Alembic Pharmaceuticals Limited Units I & II vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for Alembic Pharmaceuticals Limited Units I & II.

Alembic Pharmaceuticals Limited Units I & II: 0 warning letters, 0 recalls, 0 approval records, 1 Form 483.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

Alembic Pharmaceuticals Limited Units I & II — Warning letters0

Philips North America — Warning letters0

Alembic Pharmaceuticals Limited Units I & II — Recalls0

Philips North America — Recalls355

Alembic Pharmaceuticals Limited Units I & II — Approval records0

Philips North America — Approval records0

Alembic Pharmaceuticals Limited Units I & II — Form 483s1

Philips North America — Form 483s0

Timeline

Alembic Pharmaceuticals Limited Units I & II

Most recent FDA action: May 26, 2025

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"Alembic Pharmaceuticals Limited Units I & II vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed August 29, 2026. https://argushq.ai/compare/alembic-pharmaceuticals-limited-units-i-and-ii-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗